Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Gastrointestinal & Digestive System have been cited by esteemed scholars and scientists all around the world. Journal of Gastrointestinal & Digestive System has got h-index 15, which means every article in Journal of Gastrointestinal & Digestive System has got 15 average citations.
Following are the list of articles that have cited the articles published in Journal of Gastrointestinal & Digestive System.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
48 | 54 | 61 | 61 | 68 | 22 | 38 | 64 | 108 |
Conference proceedings |
0 | 8 | 24 | 0 | 0 | 29 | 279 | 213 | 273 |
Citations received as per Google Scholar, other indexing platforms and portals |
2091 | 162 | 165 | 210 | 220 | 230 | 230 | 221 | 312 |
Journal total citations count | 2091 |
Journal impact factor | 2.68 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 3.42 |
Journal h-index | 15 |
Journal h-index since 2019 | 11 |
Ã¥ËËè°â¹Ã¨Â£, çŽâ¹Ã¨Å½â°.(2014) èÆÆéâ¢Åä¸â¹Ã¦Â³Â¨Ã¥Â°âèâ¾ä¸Šèâ¦ÂºÃ§Â´Â èÂâÃ¥ÂËéââºÃ¥Â¤Â¹Ã¦Â²Â»Ã§ââæÅâ°Ã¦Â´Â»Ã¥Å ¨åâ¡ÂºÃ¨Â¡â¬Ã§Å¡âéžéÂâ¢Ã¨ââ°Ã¦âºÂ²Ã¥Â¼Â æâ¬Â§Ã¤Â¸Å æ¶ËÃ¥ÅâéÂâÃ¥â¡ÂºÃ¨Â¡â¬Ã¤Â¸Â´Ã¥ÂºÅ çââæâ¢Ëè§â察. æ²³åÅâÃ¥ÅȌ¦ 20: 1616-1618. |
|
| | |
Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, et al. (2015) Laboratory test variables useful for distinguishing upper from lower gastrointestinal bleeding. World Journal of Gastroenterology: WJG 21: 6246. |
|
| | |
Matei D, Groza I, Furnea B, Puie L, Levi C, et al. (2013) Predictors of variceal or nonvariceal source of upper gastrointestinal bleeding. An etiology predictive score established and validated in a tertiary referral center. J Gastrointestin Liver Dis 22: 379-384. |
|
| | |
Tomizawa M, Shinozaki F, Hasegawa R, Togawa A, Shirai Y, et al. (2014) Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding. World J Gastroenterol 20: 1311-1317. |
|
| | |
Kim KB, Yoon SM, Youn SJ (2014) Endoscopy for nonvariceal upper gastrointestinal bleeding. Clinical endoscopy 47: 315-319. |
|
| | |
Banerjee A, Shah SR, Abraham P (2015) Rectal varices in extrahepatic portal vein obstruction. Indian Journal of Gastroenterology 34: 280. |
|
| | |
ÃâðÃâ¬Ã±ÃÆ÷õýúþ ÃâÃâ (2014) ÃÂúÃâþÿøÃâ¡ÃµÃÂúøõ òðÃâ¬Ã¸ÃºÃ¾Ã·Ã½Ã¾-Ãâ¬Ã°ÃÂÃËøÃâ¬ÃµÃ½Ã½Ãâ¹Ãµ òõýÃ⹠úðú Ãâ¬ÃµÃ´ÃºÃ°Ã Ã¿Ãâ¬Ã¸Ãâ¡Ã¸Ã½Ã° öõûÃÆôþÃâ¡Ã½Ã¾-úøÃËõÃâ¡Ã½Ãâ¹Ã⦠úÃâ¬Ã¾Ã²Ã¾ÃâõÃâ¡ÃµÃ½Ã¸Ã¹. ÚûøýøÃâ¡ÃµÃÂúðàüõôøÃâ øýð 92. |
|
| | |
Sato T (2015) Treatment of ectopic varices with portal hypertension. World journal of hepatology 7: 1601. |
|
| | |
PanÃÂoška P, Skála L, Nešetà â¢il J, Carr BI (2015) Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual Patient Clinical Profile Patterns. InSeminars in oncology 42: 672-678. |
|
| | |
Carr BI. Macro-and micro-environmental factors in clinical HCC. |
|
| | |
PanÃÂoškaa P, Skálab L, Nešetà â¢ilc J, Carrd BI (2015) Evaluation of total HCC lifespan, including both clinically evident and pre-clinical development, using combined Network Phenotyping Strategy and Fisher information analysis. |
|
| | |
PanÃÂoška P, Skála L, Nešetà â¢il J, Carr BI (2015) Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and Fisher information analysis. InSeminars in oncology 42: 339-346. |
|
| | |
Carr BI, Pancoska P, Giannini EG, Farinati F, Ciccarese F, et al. (2014) Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters. InSeminars in oncology 41: 406-414. |
|
| | |
Carr BI, Guerra V, Steel JL, Lu SN (2015) A comparison of patients with hepatitis B–or hepatitis C–based advanced-stage hepatocellular carcinoma. InSeminars in oncology 42: 309-315. |
|
| | |
Pancoska P, Carr BI (2014) Macro-and micro-environmental factors in clinical hepatocellular cancer. InSeminars in oncology 41: 185-194. |
|
| | |
Hassan MR, Ismail I, Suan MA, Ahmad F, Khazim WK, et al. (2016) Incidence and mortality rates of colorectal cancer in Malaysia. Epidemiology and health. 38. |
|
| | |
Veldore VH, Rao MR, Prabhudesai SA, Tejaswi R, Kakara S, et al. (2014) Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India. Indian journal of cancer 51: 531. |
|
| | |
Hassan MR, Ismail I, Suan MA, Ahmad F, Khazim WK, et al. Alternative formats. |
|
| | |
Mishra B, Chaurasia S (2017) Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles. Therapeutic Delivery 8: 29-47. |
|
| | |
Anitha A, Maya S, Sivaram AJ, Mony U, Jayakumar R (2016) Combinatorial nanomedicines for colon cancer therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8: 151-159. |
|
| | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Journals